AR124626A1 - A SCREENING METHOD FOR DIAGNOSING GROWTH HORMONE DEFICIENCY IN PEDIATRIC PATIENTS USING MACIMORELIN - Google Patents

A SCREENING METHOD FOR DIAGNOSING GROWTH HORMONE DEFICIENCY IN PEDIATRIC PATIENTS USING MACIMORELIN

Info

Publication number
AR124626A1
AR124626A1 ARP210102035A ARP210102035A AR124626A1 AR 124626 A1 AR124626 A1 AR 124626A1 AR P210102035 A ARP210102035 A AR P210102035A AR P210102035 A ARP210102035 A AR P210102035A AR 124626 A1 AR124626 A1 AR 124626A1
Authority
AR
Argentina
Prior art keywords
growth hormone
macimorelin
pediatric patients
blood sample
hormone deficiency
Prior art date
Application number
ARP210102035A
Other languages
Spanish (es)
Inventor
Nicola Ammer
Michael Teifel
Beate Aue
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of AR124626A1 publication Critical patent/AR124626A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/61Growth hormones [GH] (Somatotropin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con un método de detección para diagnosticar una deficiencia en la hormona del crecimiento en pacientes pediátricos utilizando macimorelina. La presente invención proporciona además la sustancia macimorelina para su utilización en el diagnóstico de la deficiencia de la hormona del crecimiento en pacientes pediátricos. El método comprende proporcionar al menos una muestra de sangre, tomada de un sujeto dentro de un intervalo de aproximadamente 15 a aproximadamente 100 minutos después de una administración de una cantidad de macimorelina eficaz para inducir la secreción de la hormona del crecimiento, medir el nivel de la hormona del crecimiento de cada muestra de sangre, comparar el nivel medido de la hormona del crecimiento con un valor umbral único, diagnosticar si el sujeto sufre de deficiencia de la hormona del crecimiento o no en función de la comparación del nivel de la hormona del crecimiento con dicho valor umbral único en dicha al menos una muestra de sangre. El método de la invención es una prueba independiente y no necesita ser repetida y no se requiere ninguna prueba alternativa de estimulación de la hormona del crecimiento para realizar un diagnóstico confiable en pacientes pediátricos.The present invention relates to a detection method for diagnosing growth hormone deficiency in pediatric patients using macimorelin. The present invention further provides the substance macimorelin for use in the diagnosis of growth hormone deficiency in pediatric patients. The method comprises providing at least one blood sample, taken from a subject within an interval of about 15 to about 100 minutes after administration of an amount of macimorelin effective to induce growth hormone secretion, measuring the level of growth hormone from each blood sample, comparing the measured level of growth hormone to a single threshold value, diagnosing whether or not the subject is growth hormone deficient based on comparison of growth hormone level growth with said single threshold value in said at least one blood sample. The method of the invention is a standalone test and does not need to be repeated and no alternative growth hormone stimulation test is required to make a reliable diagnosis in pediatric patients.

ARP210102035A 2020-07-22 2021-07-20 A SCREENING METHOD FOR DIAGNOSING GROWTH HORMONE DEFICIENCY IN PEDIATRIC PATIENTS USING MACIMORELIN AR124626A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2020/070691 WO2022017599A1 (en) 2020-07-22 2020-07-22 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin

Publications (1)

Publication Number Publication Date
AR124626A1 true AR124626A1 (en) 2023-04-19

Family

ID=71784051

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102035A AR124626A1 (en) 2020-07-22 2021-07-20 A SCREENING METHOD FOR DIAGNOSING GROWTH HORMONE DEFICIENCY IN PEDIATRIC PATIENTS USING MACIMORELIN

Country Status (11)

Country Link
EP (1) EP4185866A1 (en)
JP (1) JP2023535000A (en)
KR (1) KR102635025B1 (en)
CN (1) CN114258492A (en)
AR (1) AR124626A1 (en)
AU (1) AU2020460118A1 (en)
CA (1) CA3185680A1 (en)
IL (1) IL299918A (en)
MX (1) MX2023000935A (en)
TW (1) TW202219511A (en)
WO (1) WO2022017599A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287169B6 (en) 2000-06-13 2010-02-08 Zentaris Ag Compounds increased growth hormone secretion, pharmaceutical compositions comprising thereof and their use
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
CN105209055A (en) * 2013-03-11 2015-12-30 阿穆尼克斯运营公司 Treatment of pediatric growth hormone deficiency with human growth hormone analogues
CN106310229A (en) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 Macimorelin film coated tablet and preparation method thereof
US10288629B1 (en) 2017-12-19 2019-05-14 Aeterna Zentaris, Inc. Method of assessing growth hormone deficiency in humans by a macimorelin containing composition

Also Published As

Publication number Publication date
CN114258492A (en) 2022-03-29
AU2020460118A1 (en) 2023-02-02
WO2022017599A1 (en) 2022-01-27
KR102635025B1 (en) 2024-02-07
KR20220015466A (en) 2022-02-08
TW202219511A (en) 2022-05-16
JP2023535000A (en) 2023-08-15
EP4185866A1 (en) 2023-05-31
CA3185680A1 (en) 2022-01-27
MX2023000935A (en) 2023-02-22
IL299918A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
Cosquéric et al. Sarcopenia is predictive of nosocomial infection in care of the elderly
Reid Evaluation of model systems for study of airway epithelium, cilia, and mucus
Sasano et al. Application of umami taste stimulation to remedy hypogeusia based on reflex salivation
EP3232910A1 (en) Method and apparatus for use in allergy testing
Pollock et al. Peripheral nerve morphometry in myotonic dystrophy
Puonti et al. How to assess sensory recovery after breast reconstruction surgery?
Sharma et al. Comparison of accuracy of age estimation in Indian children by measurement of open apices in teeth with the London Atlas of tooth development
Kempf et al. Evaluation of esophageal high-resolution manometry in awake and sedated dogs
Schwitzer et al. Commentary: Anatomical constitution of sense organs as a marker of mental disorders
Prince et al. Evaluation of the risk of noise-induced hearing loss among unscreened male industrial workers
AR124626A1 (en) A SCREENING METHOD FOR DIAGNOSING GROWTH HORMONE DEFICIENCY IN PEDIATRIC PATIENTS USING MACIMORELIN
Manley Frequency response of the ear of the Tokay gecko
MD3729100T2 (en) Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
Bourne et al. The permeability of the corneal endothelium to fluorescein in the normal human eye
Maurer et al. A rat in vitro model for the measurement of multiple excitability properties of cutaneous axons
Sordillo et al. A novel approach to Paget's disease diagnosis and monitoring using near-infrared absorption spectroscopy
Pincus et al. A quantitative method for the bioassay of progestin
Chemaitilly et al. Assessing short-statured children for growth hormone deficiency
Moëll et al. Blunted pubertal growth after leukemia: a new pattern of growth hormone insufficiency
Palmer et al. Endocrine analysis of childhood monorchism
Abbas et al. Salivary Cortisol Level Pre and Post MRI Scanning
Caballero et al. Placement of pH-monitoring probes using height-related formulas. Is it an applicable method to adults?
Aykal et al. Assessment of Ovarian Reserve in Patients with Migraine
Ragavan et al. Evaluation of shunt flow through a hydrocephalic shunt: a controlled model for evaluation of the performance using Shuntcheck. 1–4
Miah PWE-094 Achalasia subtype classification based on liquid swallow and solid swallow